Hormones and metabolism in blood vessel–related memory loss after menopause

Metabolic and Hormonal Mechanisms of VCID

NIH-funded research Albany Medical College · NIH-11194489

Seeks to boost brain estrogen signaling to protect memory and blood vessels in post-menopausal people at risk for vascular contributions to dementia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbany Medical College NIH-funded
Lab location1 site (Albany, United States)
Project IDNIH-11194489 on NIH RePORTER

What this research studies

This project uses menopausal and dementia models to study how losing estrogen and changes in metabolism worsen memory and brain blood vessel health. Researchers give a 17β-estradiol prodrug in mice and measure effects on cognition and blood-brain barrier or endothelial cell function. They also study human-derived brain endothelial cells and early hippocampal gene changes seen in Alzheimer disease to identify shared mechanisms. The team aims to find treatments that could work across mixed Alzheimer-plus-vascular dementia (MED).

Who could benefit from this research

Good fit: Ideal candidates would be post-menopausal people (especially women) with or at high risk for Alzheimer disease dementia that includes vascular contributions to cognitive impairment.

Not a fit: People who are pre-menopausal, whose dementia has no vascular contribution, or whose condition is driven primarily by nonvascular causes may be less likely to benefit from these specific hormone-targeted approaches.

Why it matters

Potential benefit: If successful, this work could lead to treatments that protect brain blood vessels and improve memory in post-menopausal people with vascular-related dementia.

How similar studies have performed: Early animal work from this team showed an estradiol prodrug restored cognition after menopause and other studies link estrogen signaling to blood vessel protection, but translation to human treatments remains limited.

Where this research is happening

Albany, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.